Angelique is a specialist used to juggle lots of different things. With a background in KI, where she obtained her medical degree, her path has been paved through various positions and specialist clinics. Her specialty has primarily been about preventing gynecological cancer in women and helping them find continued quality of life despite their diagnoses.
She has clinical expertise in advanced gynecological cancer surgery, especially ovarian cancer, as well as various aspects of quality of life, such as hormone replacement and sexual function after undergoing cancer treatment.
With many years of experience from a gynecological clinic for women with a hereditary risk of, among other things, gynecological cancer and BRCA mutation, to section manager for Hereditary Cancer and as “Principal investigator” for an ongoing international multicenter study in women with a BRCA mutation, you can safely say that she is an expert in her field.
“My clinical research is based on the patient groups I look after. What drives me is to be able to offer these women who have undergone cancer treatment a better quality of life and prevention against breast/ovarian cancer for women with a high risk of developing these cancers due to hereditary gene mutations.”
Angelique’s research is both clinical and translational. The translational research focuses on the prevention of breast and ovarian cancer, specifically in women who are at high risk for these types of cancer. The clinical research focuses on quality of life after cancer treatment. In her role as section manager, she also operates the continued development of an oncology centre.
She is experienced in being the main supervisor and co-supervisor for several doctoral students at KBH as well as a lecturer for many years on the bachelor programme Reproduction and Gynecology at KI. Her lecturing experience includes course leadership for a national ST course (gynecological cancer), as a guest speaker on a specialist level at national, Nordic meetings and as a recognized expert in testosterone and menopausal hormone therapy. She is also continuously involved in VFU bachelor programme in gynecology and ST oncology within Region Stockholm office for hereditary cancer.
The combined lectureship provides great opportunities for areas for integration between teaching and research in hereditary gynecological cancer, precision medicine, prevention.
“In this position, I become a good link between the clinic and research and teaching in oncogenetics/hereditary cancer, precision medicine, where we are in a paradigm shift in cancer treatment.”
Her passion for prevention and research is topped off by her love for dance which gives her energy. So it is perhaps not so strange that she is a valued lecturer (gynecology and obstetrics with a focus on cancer prevention) at KBH.
